Holocene Advisors, LP Ironwood Pharmaceuticals Inc Transaction History

Holocene Advisors, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$8.99 - $10.74 $255,073 - $304,726	-28,373 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$9.14 - $11.97 $259,329 - $339,624	28,373 New	28,373 $293,000
Q2 2018 Aug 14, 2018	SELL	$11.83 - $16.2 $190,273 - $260,560	-16,084 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$11.13 - $13.63 $213,028 - $260,878	-19,140 Reduced 54.34%	16,084 $248,000
Q4 2017 Feb 14, 2018	BUY	$12.16 - $14.58 $428,323 - $513,565	35,224	35,224 $528,000

237

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $679M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.